FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 329:1377-1382 November 4, 1993 Number 19 Next

	Full Text Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background For patients with invasive bladder cancer the usual recommended treatment is radical cystectomy, although transurethral resection of the tumor, systemic chemotherapy, and radiotherapy are each effective in some patients. We sought to determine whether these treatments in combination might be as effective as radical cystectomy and thus might allow the bladder to be preserved and the cancer cured.

Methods We enrolled 53 consecutive patients with muscle-invading bladder cancer (stages T2 through T4, NXM0) in a trial of transurethral surgery, combination chemotherapy, and irradiation (4000 cGy) with concurrent cisplatin administration. Urologic evaluation of the tumor response directed further therapy: radical cystectomy in the 8 patients who had incomplete responses, additional chemotherapy and radiotherapy (6480 cGy) in the 34 patients who had complete responses or who were unsuited for cystectomy, and alternative care in the 11 patients who could not tolerate either irradiation or chemotherapy.

Results After a median follow-up of 48 months, 24 of the 53 patients (45 percent) were alive and free of detectable tumor. In 31 patients (58 percent) the bladder was free of invasive tumor and functioning well, even though in 9 (17 percent) a superficial tumor recurred and required further transurethral surgery and intravesical drug therapy. Of the 28 patients who had complete responses after initial treatment, 89 percent had functioning tumor-free bladders.

Conclusions Conservative combination treatment may be an acceptable alternative to immediate cystectomy in selected patients with bladder cancer, although a randomized clinical trial that included a group for simultaneous comparison would be required to produce definitive results.

Source Information

From the Departments of Medical Oncology (D.S.K.), Radiation Oncology (W.U.S., J.T.E.), and Urology (P.P.G., N.M.H., A.F.A.), Massachusetts General Hospital and Harvard Medical School, Boston.

Address reprint requests to Dr. Kaufman at MGH Cancer Center, Massachusetts General Hospital, Fruit St., Boston, MA 02114.

Full Text of this Article

Related Letters:

Bladder Preservation after Treatment of Invasive Bladder Cancer
Lytton B., Berman D. J., Kaufman D. S., Shipley W. U., Heney N. M., Althausen A. F.
Extract | Full Text  
N Engl J Med 1994; 330:867-868, Mar 24, 1994. Correspondence

This article has been cited by other articles:

• Efstathiou, J. A., Bae, K., Shipley, W. U., Kaufman, D. S., Hagan, M. P., Heney, N. M., Sandler, H. M. (2009). Late Pelvic Toxicity After Bladder-Sparing Therapy in Patients With Invasive Bladder Cancer: RTOG 89-03, 95-06, 97-06, 99-06. JCO 27: 4055-4061 [Abstract] [Full Text]  
• Kaufman, D. S., Shipley, W. U., McDougal, W. S., Young, R. H. (2004). Case 3-2004 - A 57-Year-Old Man with Invasive Transitional-Cell Carcinoma of the Bladder. NEJM 350: 394-402 [Full Text]  
• Kaufman, D. S., Winter, K. A., Shipley, W. U., Heney, N. M., Chetner, M. P., Souhami, L., Zlotecki, R. A., Sause, W. T., True, L. D. (2000). The Initial Results in Muscle-Invading Bladder Cancer of RTOG 95-06: Phase I/II Trial of Transurethral Surgery Plus Radiation Therapy with Concurrent Cisplatin and 5-Fluorouracil Followed by Selective Bladder Preservation or Cystectomy Depending on the Initial Response. The Oncologist 5: 471-476 [Abstract] [Full Text]  
• Eisenberger, C. F., Schoenberg, M., Enger, C., Hortopan, S., Shah, S., Chow, N.-H., Marshall, F. F., Sidransky, D. (1999). Diagnosis of Renal Cancer by Molecular Urinalysis. JNCI J Natl Cancer Inst 91: 2028-2032 [Abstract] [Full Text]  
• (1999). . JCO 17: 1326a-1326  
• Lichter, A. S., Lawrence, T. S. (1995). Recent Advances in Radiation Oncology. NEJM 332: 371-379 [Full Text]  
• Hellman, S., Weichselbaum, R. R. (1994). Radiation Oncology. JAMA 271: 1712-1714 [Abstract]  
• Lytton, B., Berman, D. J., Kaufman, D. S., Shipley, W. U., Heney, N. M., Althausen, A. F. (1994). Bladder Preservation after Treatment of Invasive Bladder Cancer. NEJM 330: 867-868 [Full Text]  
• Scher, H. I. (1993). New Approaches to the Treatment of Bladder Cancer. NEJM 329: 1420-1421 [Full Text]